Fecal neuraminidase correlates with inflammatory signatures and microbiome shifts in preclinical Crohn’s disease
15 affiliations
- 1Division of Gastroenterology & Hepatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- 2Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada
- 3Division of Gastroenterology and Nutrition, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
- 4IBD Centre, The Hospital for Sick Children, Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- 5The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, The Eisenberg R&D Authority, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel
- 6Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada
- 7Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 8Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada
- 9Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada
- 10Division of Gastroenterology, Hepatology & Nutrition, Children’s Hospital of Eastern Ontario and University of Ottawa, Ottawa, Ontario, Canada
- 11Division of Gastroenterology, Department of Medicine, University of British Columbia, BC Children’s Hospital, and BC Children’s Hospital Research Institute, Vancouver, British Columbia, Canada
- 12Department of Medicine, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada
- 13Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
- 14University of British Columbia, Vancouver, British Columbia, Canada
- 15Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Abstract
The mucus layer, rich in mucin glycoproteins, serves as a critical barrier to microbial invasion. Neuraminidases cleave terminal sialic acids from mucin glycans, a process that may influence mucus integrity, epithelial exposure to microbial antigens, and mucosal immune responses, making fecal neuraminidase activity a biologically relevant functional readout of host-microbe interactions in the context of Crohn’s disease (CD) pathogenesis. We evaluated whether fecal neuraminidase activity is associated with future CD risk and examine its relationships with inflammatory and microbial signatures relevant to early disease development. Within the prospective GEM cohort, 69 individuals who later developed CD were matched to 69 healthy first-degree relative controls. Fecal neuraminidase activity was measured using a fluorometric assay. Conditional logistic regression assessed its association with future CD risk. Partial Spearman correlations evaluated relationships with 446 serum proteins (OLINK), followed by pathway enrichment analysis, and with fecal calprotectin (FCP) and gut microbial composition (16S rRNA sequencing). Fecal neuraminidase activity was positively associated with future CD (OR = 1.541; 95% CI: 1.05–2.25; p = 0.026). Proteins correlated with neuraminidase activity were enriched in immune and inflammatory pathways. Neuraminidase activity was positively correlated positively with FCP (p ≤ 0.05), and its association with future CD was attenuated after adjustment for FCP. Fourteen microbial taxa were significantly correlated with neuraminidase activity (q ≤ 0.05). Fecal neuraminidase activity's relationships with inflammatory markers and microbial taxa support its potential relevance as a functional marker of host-microbe alterations during preclinical CD.
Related
- Discovering gut microbiome signatures that predict adverse and reverse cardiac remodeling in preclinical heart failure
- Gut microbiome-derived metabolic remodeling and the butyrate-IL-18 inflammatory axis after transcatheter aortic valve implantation
- Preclinical Mouse Models of Rheumatoid Arthritis: Comparative Insights into Inflammatory Mediators and Immune Cells
- Paired biopsy-surface and tissue microbiome profiling reveals tissue-associated bacterial signatures in nasopharyngeal carcinoma.
- Genetic and circulating inflammatory cytokine signatures for renal cell carcinoma risk: a case-control study from Northwest China
BibTeX
@article{mu2026fecal,
title = {{Fecal neuraminidase correlates with inflammatory signatures and microbiome shifts in preclinical Crohn’s disease}},
author = {Kaiwen Mu and Cong Phi Dang and Mingyue Xue and Qilong Li and Hien Q. Huynh and Anne M. Griffiths and Dan Turner and Paul Moayyedi and A. Hillary Steinhart and Levinus A. Dieleman and Colette Deslandres and Alain Bitton and David R. Mack and Kevan Jacobson and Maria Cino and Guy Aumais and Remo Panaccione and Brian Bressler and Sun-Ho Lee and Kenneth Croitoru and Williams Turpin},
journal = {Gut Microbes},
year = {2026},
month = nov,
doi = {10.1080/19490976.2026.2755166},
url = {https://doi.org/10.1080/19490976.2026.2755166},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Fecal neuraminidase correlates with inflammatory signatures and microbiome shifts in preclinical Crohn’s disease
AU - Kaiwen Mu
AU - Cong Phi Dang
AU - Mingyue Xue
AU - Qilong Li
AU - Hien Q. Huynh
AU - Anne M. Griffiths
AU - Dan Turner
AU - Paul Moayyedi
AU - A. Hillary Steinhart
AU - Levinus A. Dieleman
AU - Colette Deslandres
AU - Alain Bitton
AU - David R. Mack
AU - Kevan Jacobson
AU - Maria Cino
AU - Guy Aumais
AU - Remo Panaccione
AU - Brian Bressler
AU - Sun-Ho Lee
AU - Kenneth Croitoru
AU - Williams Turpin
PY - 2026
DA - 2026/11/05
JO - Gut Microbes
DO - 10.1080/19490976.2026.2755166
UR - https://doi.org/10.1080/19490976.2026.2755166
AB - The mucus layer, rich in mucin glycoproteins, serves as a critical barrier to microbial invasion. Neuraminidases cleave terminal sialic acids from mucin glycans, a process that may influence mucus integrity, epithelial exposure to microbial antigens, and mucosal immune responses, making fecal neuraminidase activity a biologically relevant functional readout of host-microbe interactions in the context of Crohn’s disease (CD) pathogenesis. We evaluated whether fecal neuraminidase activity is associated with future CD risk and examine its relationships with inflammatory and microbial signatures relevant to early disease development. Within the prospective GEM cohort, 69 individuals who later developed CD were matched to 69 healthy first-degree relative controls. Fecal neuraminidase activity was measured using a fluorometric assay. Conditional logistic regression assessed its association with future CD risk. Partial Spearman correlations evaluated relationships with 446 serum proteins (OLINK), followed by pathway enrichment analysis, and with fecal calprotectin (FCP) and gut microbial composition (16S rRNA sequencing). Fecal neuraminidase activity was positively associated with future CD (OR = 1.541; 95% CI: 1.05–2.25; p = 0.026). Proteins correlated with neuraminidase activity were enriched in immune and inflammatory pathways. Neuraminidase activity was positively correlated positively with FCP (p ≤ 0.05), and its association with future CD was attenuated after adjustment for FCP. Fourteen microbial taxa were significantly correlated with neuraminidase activity (q ≤ 0.05). Fecal neuraminidase activity's relationships with inflammatory markers and microbial taxa support its potential relevance as a functional marker of host-microbe alterations during preclinical CD.
SN - 1949-0976
SN - 1949-0984
ER -